Huihe Medical's K-Clip® Transcatheter Tricuspid Annuloplasty System Granted Another U.S. Patent
H&H Healthcare
R&D and Producer of Interventional Medical Devices for Heart Disease
Recently, Shanghai Huihe Healthcare Technology Co., Ltd. (hereinafter referred to as "HuiHe Healthcare")K-Clip®Another Invention Patent of the Transcatheter Tricuspid Annuloplasty System Successfully Granted by the US Patent and Trademark Office. This achievement follows the K-Clip®This is another successful overseas authorization of the core invention patent of HuiHe Healthcare's products, following authorizations in the United States, Canada, and the European Union, further strengthening the company's patent protection system abroad.
During the application process of this invention patent, HuiHe HealthcarePioneering the use of the PPH (Patent Prosecution Highway) program, with great success.This application took only half a year from entering the U.S. national phase to obtaining authorization.
The authorization of this invention patent is a result of HuiHe Healthcare's K-Clip team.®Based on core patents, continuous improvements have endowed the product with entirely new functions, making it more effective in benefiting a wide range of patients. Its related product patents have successfully obtained authorization in China prior to this.
HuiHe Healthcare always prioritizes the construction of an intellectual property system and the cultivation of high-value patents. HuiHe Healthcare and its wholly-owned subsidiary, Suzhou Zhonghui Medical Technology Co., Ltd., strictly adhere to the GB/T29490-2013 standard, establishing a comprehensive intellectual property system, and have respectively obtained certification for corporate intellectual property compliance. In 2023, HuiHe Healthcare was further recognized as...Shanghai Patent Work Pilot Enterprise, National Intellectual Property Advantage Enterprise。
As of now, HuiHe Healthcare has filed over 300 patent applications, including more than 150 invention patents, and has been granted over 100 patents, of which more than 70 are invention patents. In addition, HuiHe Healthcare has applied for more than 10 patents overseas via the PCT pathway, successfully obtaining authorization in the United States, Canada, and the European Union.
Xu Jun
Chief Technology Officer of HuiHe Healthcare
The successful granting of this U.S. patent furtherEnhanced K-Clip®Intellectual Property Barriers of Transcatheter Tricuspid Annuloplasty Systems, and also forThis product's entry into overseas markets has laid a more solid foundation.。At the same time, we feel deeply honored that HuiHe Healthcare can contribute to the efforts of China's locally innovated medical devices entering the overseas market.
